Joseph J Wolk $JNJ SEC Form 4 Insider Trading

Joseph J Wolk has filed a total of 4 insider trades in $JNJ since 2021. Their most recent trade was a sale of 16,820 shares, made on Aug 15, 2025. Their largest trade was a sale of 16,820 shares, made on Aug 15, 2025. We estimate that they now own 82,835 shares of $JNJ, worth an estimated $14.8 million.

Insider Trading at $JNJ

There have been a total of 352 insider trades reported at $JNJ since 2021, with 1,000 shares purchased and 693,432 shares sold. The most active insider traders in $JNJ stock have been Peter Fasolo, Thibaut Mongon, and William Hait. The most recent trade was a sale of 16,820 shares reported by Joseph J Wolk (Exec VP, CFO), made on Aug 15, 2025.

$JNJ Executives and Stock Owners with Insider Trades

• Peter Fasolo, Exec VP, Chief HR Officer

• Thibaut Mongon, Exec VP, WW Chair, Consumer

• William Hait, See Remarks

• Kathryn E Wengel, EVP, Chief GSC Officer

• Joseph J Wolk, Exec VP, CFO

• Robert J Decker, Controller, CAO

• Ashley Mcevoy, EVP, WW Chair, MedTech

• Jennifer L Taubert, EVP, WW Chair, Pharmaceuticals

• Robert J Decker, VP Corporate Controller

• John C Reed, EVP, Innovative Medicine, R&D

• James D. Swanson, See Remarks

• Kathryn E Wengel, EVP, Chief TO and Risk Officer

• Timothy Schmid, EVP, WW Chair, MedTech

• Vanessa Broadhurst, EVP, Global Corp Affairs

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.